Efficacy Comparison of Preprandial and Postprandial Prandilin 25 Administration in Patients with Newly Diagnosed Type 2 Diabetes Using a Continuous Glucose Monitoring System

被引：0
|
作者：
Yong Luo
Wen-ji Ni
BO Ding
Xiang-hong Xu
Lei Ye
Jian-hua Ma
Jian Zhu
机构：
[1] Nanjing Medical University,Department of Endocrinology, Nanjing First Hospital
[2] National Heart Research Institute Singapore,undefined
[3] National Heart Centre,undefined
来源：
Diabetes Therapy | 2019年 / 10卷
关键词：
Continuous glucose monitoring; Postprandial administration; Prandilin 25; T2DM;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：205 / 213
页数：8
相关论文
共 50 条
  • [41] Broadening Access to Continuous Glucose Monitoring for Patients With Type 2 Diabetes
    Peek, Monica E.
    Thomas, Celeste C.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (22): : 2255 - 2257
  • [42] Awareness of Postprandial Blood Glucose Monitoring Improved Glycemia in Patients with Type 2 Diabetes
    Yang, Yi-Sun
    Wu, Yueh Chu
    Huang, Chien Ning
    DIABETES, 2015, 64 : A189 - A189
  • [43] Both Nateglinide and Acarbose Improve Postprandial Ghrelin Response in Patients With Newly Diagnosed Type 2 Diabetes
    Zheng, Fenping
    Yin, Xueyao
    Lu, Weina
    Zhou, Jiaqiang
    Li, Hong
    DIABETES, 2012, 61 : A703 - A704
  • [44] EFFICACY OF SAXAGLIPTIN THERAPY FOR PATIENTS WITH TYPE 2 DIABETES AND METFORMIN INTOLERANCE CONFIRMED BY CONTINUOUS GLUCOSE MONITORING
    Ulyanova, O.
    Taubaldieva, Z.
    Kozina, L.
    Zelenskaya, V.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2013, 15 : A34 - A34
  • [45] Efficacy of Additional Canagliflozin Administration to Type 2 Diabetes Patients Receiving Insulin Therapy: Examination of Diurnal Glycemic Patterns Using Continuous Glucose Monitoring (CGM)
    Mihoko Matsumura
    Yuki Nakatani
    Seiichi Tanka
    Chie Aoki
    Masaaki Sagara
    Kazunori Yanagi
    Kunihiro Suzuki
    Yoshimasa Aso
    Diabetes Therapy, 2017, 8 : 821 - 827
  • [46] Autonomic dysfunction is associated with loss of postprandial glycaemic control in newly diagnosed type 2 diabetes patients
    Dejgaard, T. F.
    Fleischer, J.
    Cichosz, S. L.
    Hoeyem, P.
    Laugesen, E.
    Poulsen, P. L.
    Christiansen, J. S.
    Tarnow, L.
    Hansen, T. K.
    DIABETOLOGIA, 2014, 57 : S460 - S461
  • [47] Efficacy of Additional Canagliflozin Administration to Type 2 Diabetes Patients Receiving Insulin Therapy: Examination of Diurnal Glycemic Patterns Using Continuous Glucose Monitoring (CGM)
    Matsumura, Mihoko
    Nakatani, Yuki
    Tanka, Seiichi
    Aoki, Chie
    Sagara, Masaaki
    Yanagi, Kazunori
    Suzuki, Kunihiro
    Aso, Yoshimasa
    DIABETES THERAPY, 2017, 8 (04) : 821 - 827
  • [48] ESMON Study Group: Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial
    Pendergrass, Merri
    DIABETES CARE, 2008, 31 (07) : 1469 - 1469
  • [49] Jointly Predicting Postprandial Hypoglycemia and Hyperglycemia Using Continuous Glucose Monitoring Data in Type 1 Diabetes
    Cui, Ran
    Nolan, Christopher J.
    Daskalaki, Elena
    Suominen, Hanna
    2023 45TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE & BIOLOGY SOCIETY, EMBC, 2023,
  • [50] Continuous glucose monitoring in persons with type 2 diabetes not using insulin
    Cowart, Kevin
    Updike, Wendy H.
    Franks, Rachel
    EXPERT REVIEW OF MEDICAL DEVICES, 2021, 18 (11) : 1049 - 1055
12345